Stride Pharma gains 12.33% after news with SUD, page-3

Hi all

I had an interesting discussion with the Company yesterday which I will elaborate on latter, time permitting.

But I did want to quickly mention two things.

One, our deals are evolving as we move forward, this deal was concluded quite dome time ago but was held up by Strides and not Suda.

The second thing is this deal was done on our new IP platform, the validation of that by this medium sized Pharma is of huge importance to Suda and the market.  It will see others now move more quickly based on the fear of missing out.

These deals are heavily royalty based deals with the first two being double digit royalties which are an outstanding result.

I have voted yes to all motions as a result of a) speaking to the Company b) I liked the Boardroom Radio interviews and c) the lattest deal.

Things may just have at last turned a corner.

Clyde